Tag
Tag: Forbion Capital Partners
Anti-Inflammatory Treatments Get €40M Boost in Series B
Update: Forbion’s Life Science Fund Tops Goal by €90M
British Biotech Raises £29M Round to Fight Lung Disease
Dutch Biotech Raises $19M to Treat Psoriasis Without Injections
New Dutch Biotech Sails Straight into Phase II with €25M Series A to Treat NASH
“We’re at a second revolution in cancer therapy” – Experts discuss the Future of Oncology at Refresh
Meet the co-developer of the first commercial mAb and gene therapy
Why did Biotech Beat Pharma to Bring the First Gene Therapy to Market?
Swiss Parkinson’s Biotech raises Massive €29M in Series B from Top European VCs
Not to be Underestimated: What’s the Hype around NASH?
